Biosafety Level 3 Containment Services

We are dedicated to making significant advances in health safety, and our A/BSL-3 services exemplify this commitment. Combining broad-ranging expertise, rigorous safety protocols, small and large animal testing abilities, and state-of-the-art facilities, we strive to make substantial differences in global health outcomes. We have been performing infectious disease research for 80+ years for commercial, government, and academic clients and collaborators.

SR-Anatomic-Pathology-Hero-Image-1

Advancing Infectious Disease Research & Establishing Pandemic Preparedness

Your Trusted Partner for BSL-3 Select Agent Containment Research

Our BSL-3 facilities are designed to meet the highest standards of safety and containment, enabling the safe handling of potent and potentially lethal pathogens. Our comprehensive services encompass:

1. Advanced BSL-3 Laboratory Facilities:

  • Accredited BSL-3 laboratories equipped with all the equipment necessary to assure the highest level of biosafety.
  • The abilitity to conduct small to large animal (NHP) in vivo studies in BSL-3.
  • We can also conduct high-throughput screening, in vitro studies, and clinical and anatomic pathology capabilities in BSL-3.

2. Expert Scientific Team:

  • Experienced scientists with comprehensive knowledge of BSL-3 regulations and protocols, ensuring the safe and effective conduct of your research.
  • Expertise in a wide range of research disciplines, including virology, bacteriology, high throughput screen for BSL-3 agents, and infectious disease research, to cater to your specific needs.
  • Collaborative and communicative team dedicated to providing ongoing support and guidance throughout your research project.

3. Customized Research Solutions:

  • Tailored research services designed to meet your specific project objectives, from feasibility studies to full-scale research projects.
  • Access to cutting-edge technologies and methodologies to facilitate groundbreaking research on high-containment pathogens.
  • Flexible project management and clear communication to ensure seamless collaboration and timely completion of your research.

4. Regulatory Support and Compliance:

  • Expert guidance on navigating regulatory requirements for BSL-3 research, including biosafety protocols and documentation.
  • Assistance with regulatory submissions and ongoing communication with regulatory authorities to ensure compliance.

5. Unwavering Commitment to Safety and Ethics:

We firmly believe that responsible biosafety practices are paramount to ensuring the safety of our researchers, the environment, and the public. Our commitment to ethical research translates into:

  • Rigorous adherence to the highest biosafety standards and regulations.
  • Continuous investment in advanced safety technologies and training programs.
  • Open communication and transparency throughout the research process.

BSL-3 Expertise: Partner With Us

Let us be your trusted partner in navigating the complex and demanding field of BSL-3 research. Our commitment to safety, expertise, and collaboration will empower you to conduct your research with confidence and contribute to groundbreaking discoveries that improve human health and well-being.

Contact us today to discuss your specific BSL-3 research needs and embark on a journey towards impactful discoveries in a secure and controlled environment.

Southern Research News

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow 

December 11, 2024

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow     BIRMINGHAM, AL. Dec...
Read More
Biotech incubator Station 41 fills up with plans to expand

Biotech incubator Station 41 fills up with plans to expand

November 21, 2024

Southern Research’s biotech incubator, Station 41 fills up with plans to expand. The pilot space for the Incubator was unveiled in January 2024 with twelve private leasable wet labs (325-625 square feet) and 13 private offices (125-200 sq. ...
Read More

MyOme and Broad Clinical Labs to support Southern Research program to bring genetics-driven health insights to Alabamians free of charge

October 14, 2024

MyOme, Inc., a leading clinical genetics innovation company, and Broad Clinical Labs (BCL), a world expert in whole genome sequencing (WGS) are announcing a collaboration to support the Southern Research (SR) program, Catalyst. SR is a leading nonprofit research organization committed to advan...
Read More